Advertisement

Cyclophosphamide pulse therapy in optic neuritis due to systemic lupus erythematosus: an open trial

      Abstract

      OBJECTIVE: To evaluate the efficacy of intravenous cyclophosphamide pulse therapy in patients with optic neuritis associated with systemic lupus erythematosus (SLE).
      PATIENTS AND METHODS: Ten consecutive patients with optic neuritis due to SLE whose condition was refractory to corticosteroids and oral immunosuppressants were treated with intravenous cyclophosphamide (0.5 to 1.0 g/m2) monthly for 6 months.
      RESULTS: All patients had bilateral eye involvement. One eye was legally blind, and 13 eyes could see only hand movements or count fingers. Six patients had evidence of the secondary antiphospholipid antibody syndrome. Complete recovery in visual acuity occurred in 10 eyes (50%), and a partial response occurred in six eyes (30%); four eyes (20%) had no response. Complete response in the field tests occurred in eight eyes (40%), with a partial response in nine eyes (45%); no improvement occurred in three eyes (15%).
      CONCLUSIONS: Intravenous cyclophosphamide pulse therapy seems to be an effective treatment for optic neuritis refractory to corticosteroids, oral immunosuppressants, or both. A randomized controlled trial will be necessary to confirm our results.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kaposi M.K
        Neue Neue breitrage zur kenntniss des lupus erythematosus.
        Arch Derm Syph. 1872; 4: 36-78
        • Feinglass E.J
        • Arnett F.C
        Neuropsychiatric manifestations of systemic lupus erythematosus.
        Medicine. 1976; 55: 323-330
        • Lee P
        • Urowitz M.B
        • Bookman A.A
        Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infection, aseptic necrosis and prognosis.
        Q J Med. 1977; 181: 1-15
        • Abel T
        • Gladman D
        Neuropsychiatric lupus.
        J Rheumatol. 1980; 7: 325-330
        • Johnson R.T
        • Richardson E.D
        The neurologic manifestation of systemic lupus erythematosus. A clinical-pathological study of 24 cases and review of the literature.
        Medicine. 1968; 47: 337-345
        • Gold D.H
        • Morris D.A
        • Henkid P
        Ocular findings in systemic lupus erythematosus.
        Br J Ophthal. 1972; 56: 800-804
        • Stafford-Brady F.J
        • Urowitz M.B
        • Gladman D
        • Easterbrook M
        Lupus retinopathy. Patterns, association, and prognosis.
        Arth Rheum. 1988; 31: 1105-1110
        • Drosos A.A
        • Petris C.A
        • Petroutsos G.M
        • Moutsopoulus H.M
        Unusual eye manifestations in systemic lupus erythematosus patients.
        Clin Rheumatol. 1989; 8: 49-53
        • Cinefro R.J
        • Frenkel M
        Systemic lupus erythematosus presenting as optic neuritis.
        Ann Ophthalmol. 1978; 5: 559-563
        • Oppenheimer S
        • Hoffbrand B.I
        Optic neuritis and myelopathy in systemic lupus erythematosus.
        Can J Neurol Sci. 1986; 13: 129-132
        • Levine S.R
        • Crofts J.W
        • Lesser G.R
        • Floberg J
        • Welch K.M.A
        Visual symptoms associated with the presence of a lupus anticoagulant.
        Ophthalmology. 1988; 95: 686-692
        • Jabs D.A
        • Miller N.R
        • Newman S.A
        • Johnson M.A
        • Stevens M.B
        Optic neuropathy in systemic lupus erythematosus.
        Arch Ophthalmol. 1986; 104: 564-568
        • Kupersmith M.J
        • Burden R.M
        • Warren F.A
        • Klingele T
        • Frohman L.P
        • Mitnick H
        Autoimmune optic neuropathy.
        J Neurol Neurosurg Psychiatr. 1988; 51: 1381-1386
        • Kenik J.G
        • Khron K
        • Kelly R.B
        • Bierman M
        • Hameke M.D
        • Hurley J.A
        Transverse myelitis and optic neuritis in systemic lupus erythematosus.
        Arth Rheum. 1987; 30: 947-950
        • Kinney E.L
        • Berdoff R.L
        • Rao N.S
        • Fox L.M
        Devic’s syndrome and systemic lupus erythematosus. A case report with necropsy.
        Arch Neurol. 1979; 36: 643-644
        • Wanvarie S
        • Kitiponghasa S
        • Watanasuk M
        • Kanchanaranya C.H
        Decreased visual acuity without optic neuritis. An unusual presentation of SLE.
        J Med Ass Thailand. 1979; 62: 216-220
        • Spoor T.C
        Treatment of optic neuritis with megadose corticosteroids. A consecutive series.
        Ophthalmology. 1988; 95: 131-134
        • Deutsch T.H
        • Corwin H.L
        Lupus optic neuritis with negative serology.
        Ann Ophthalmol. 1988; 20: 383-384
        • Tola M.R
        • Granieri E
        • Caniatti L
        • et al.
        Systemic lupus erythematosus presenting with neurological disorders.
        J Neurol. 1992; 239: 61-64
        • Ahmadieh H
        • Roodpeyna S
        • Azarmina M
        • Soheilian M
        • Sajjadi S.H
        Bilateral simultaneous optic neuritis in childhood systemic lupus erythematosus. A case report.
        J Neuro-ophthalmol. 1994; 14: 84-86
        • April R.S
        • Vansonnber E
        A case of neuromyelitis optica (Devic’s syndrome) in systemic lupus erythematosus. Clinicopathologic report and review of the literature.
        Neurology. 1976; 26: 1066-1070
        • Smith C
        • Pinals R.S
        Optic neuritis in systemic lupus erythematosus.
        J Rheumatol. 1982; 9: 963-966
        • De Vita S
        • Neri R
        • Bombardieri N.S
        Cyclophosphamide pulses in the treatment of rheumatic diseases.
        Clin Exp Rheumatol. 1991; 9: 179-193
        • Tan E.M
        • Cohen A.A.S
        • Fries J.F
        • et al.
        The 1982 revised criteria for the classification of systemic lupus erythematosus.
        Arthritis Rheum. 1982; 25: 1271-1277
        • Wilson B
        Visual-evoked response differentiation of ischemic optic neuritis from the optic neuritis of multiple sclerosis.
        Am J Ophthalmol. 1978; 86: 530-535
        • Harris E.N
        • Asherson R.A
        • Gharavi A.E
        • et al.
        Anticardiolipin antibodies.
        Lancet. 1983; ii: 1211-1214
        • Kinnunen E
        • Muler K
        • Ketonen L
        • Helve
        • Sepponen R
        Cerebrospinal fluid and MRI findings in three patients with multiple sclerosis and systemic lupus erythematosus.
        Acta Neurol Scand. 1993; 87: 356-360
        • Asherson R.A
        • Cervera R
        Antiphospholipid syndrome.
        in: Kelley W.N Textbook of Rheumatology. 5th ed. WB Saunders, Philadelphia1997: 1057-1064
        • Rosler D.H
        • Conway M.D
        • Anaya J.M
        • et al.
        Ischemic optic neuropathy and high-level anticardiolipin antibodies in primary Sjögren’s syndrome.
        Lupus. 1995; 4: 155-157
        • Galetta S.L
        • Plock G.L
        • Brucker A.J
        Ocular thrombosis with antiphospholipid antibodies.
        Ann Ophthalmol. 1991; 23: 207-212
        • Asherson R.A
        • Merry P
        • Acheson J.F
        • Harris E.N
        • Hughes G.R.V
        Antiphospholipid antibodies.
        Ann Rheum Dis. 1989; 48: 358-361
        • Lavalle C
        • Pizarro S
        • Drenkard C
        • Sánchez-Guerrero J
        • Alarcón-Segovia D
        Transverse myelitis.
        J Rheumatol. 1990; 17: 34-37